{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:16:52Z","timestamp":1792001812513,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2020-I2M-1-001"],"award-info":[{"award-number":["2020-I2M-1-001"]}]},{"name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","award":["2021-1-I2M-044"],"award-info":[{"award-number":["2021-1-I2M-044"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2021T140068"],"award-info":[{"award-number":["2021T140068"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Herpes zoster increases the burden on the elderly in an aging society. Although an effective vaccine licensed by China Food and Drug Administration in 2019 was introduced into the market in June 2020, the willingness and influencing factors of herpes zoster vaccines in Chinese adults\u2009\u2265\u200950-years-old during coronavirus disease-2019 pandemic are yet to be elucidated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An online questionnaire survey was conducted using a simple random sampling method in October 2021 for viewers of the broadcast program. A binary logistic regression and multiple response analysis were conducted for herpes zoster vaccine and vaccination willingness. Pareto\u2019s graphs were plotted to present the multiple-choice questions of influencing factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 3838 eligible participants were included in this study. Among them, 43.02% intended to be vaccinated, including 10.34% self-reported about receiving at least one shot of shingles vaccine, 30.22% declined, and 26.76% were hesitant. This population comprised a large proportion of middle-aged and older people (\u2265\u200950-years-old) who have not experienced an episode of herpes zoster (54.98%) or are unaware of the virus (33.22%). The strongest determinants of vaccine hesitancy among older people were education background of Master\u2019s degree or above compared to senior high or equivalent and below, personal monthly income\u2009&lt;\u20093000 RMB compared to 3000\u20135999 RMB, and living in a rural area.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The willingness to get shingles vaccines can be improved further. Professional education and credible recommendation might prompt the elderly to improve their willingness and reassure them of the safety and efficacy of the vaccine. Also, accessibility and affordability should also be improved in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07840-2","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:18:52Z","timestamp":1669511932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Willingness to accept herpes zoster vaccines and the influencing factors in China"],"prefix":"10.1186","volume":"22","author":[{"given":"Binshan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-7181","authenticated-orcid":false,"given":"Mengmeng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luzhao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"7840_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3389\/fimmu.2020.00717","volume":"11","author":"A Wagner","year":"2020","unstructured":"Wagner A, Weinberger B. Vaccines to prevent infectious diseases in the older population: immunological challenges and future perspectives. Front Immunol. 2020;11:717.","journal-title":"Front Immunol"},{"key":"7840_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40121-021-00567-8","volume":"11","author":"D Curran","year":"2022","unstructured":"Curran D, Callegaro A, Fahrbach K, Neupane B, Vroling H, van Oorschot D, et al. Meta-regression of herpes zoster incidence worldwide. Infect Dis Ther. 2022;11:389\u2013403.","journal-title":"Infect Dis Ther"},{"key":"7840_CR3","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","volume":"81","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81:928\u201330.","journal-title":"Neurology"},{"key":"7840_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833","volume":"6","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;6: e004833.","journal-title":"BMJ Open"},{"key":"7840_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/14787210.2020.1792290","volume":"19","author":"D Yin","year":"2021","unstructured":"Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, et al. A systematic literature review to assess the burden of herpes zoster disease in China. Expert Rev Anti Infect Ther. 2021;19:165\u201379.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"7840_CR6","doi-asserted-by":"publisher","unstructured":"Bricout H, Haugh M, Olatunde O, Prieto RG. Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health. 2015;15:466. https:\/\/doi.org\/10.1186\/s12889-015-1753-y.","DOI":"10.1186\/s12889-015-1753-y"},{"key":"7840_CR7","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"22","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang S-J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;22:2087\u201396.","journal-title":"N Engl J Med"},{"key":"7840_CR8","doi-asserted-by":"publisher","unstructured":"Cunningham AL, Lal H, Kovac M, Chlibek R, Hwang SJ, D\u00edez-Domingo J, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375(11):1019\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1603800.","DOI":"10.1056\/NEJMoa1603800"},{"key":"7840_CR9","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1080\/21645515.2019.1627818","volume":"12","author":"L Oostvogels","year":"2019","unstructured":"Oostvogels L, Heineman TC, Johnson RW, Levin MJ, McElhaney JE, Steen PVD, et al. Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials. Hum Vaccin Immunother. 2019;12:2865\u201372.","journal-title":"Hum Vaccin Immunother."},{"key":"7840_CR10","doi-asserted-by":"publisher","unstructured":"Godeaux O, Kovac M, Shu D, Grupping K, Campora L, Douha M, et al. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults \u2265 50 years of age with a prior history of herpes zoster: a phase III, non-randomized, open-label clinical trial. Hum Vaccin Immunother. 2017;13(5):1051\u20138. https:\/\/doi.org\/10.1080\/21645515.2016.1265715.","DOI":"10.1080\/21645515.2016.1265715"},{"key":"7840_CR11","doi-asserted-by":"publisher","unstructured":"Lu X, Lu J, Zhang F, Wagner AL, Zhang L, Mei K, et al. Low willingness to vaccinate against herpes zoster in a Chinese metropolis. Hum Vaccin Immunother. 2021;17(11):4163\u201370. https:\/\/doi.org\/10.1080\/21645515.2021.1960137.","DOI":"10.1080\/21645515.2021.1960137"},{"issue":"307\u201310","key":"7840_CR12","first-page":"27","volume":"27","author":"JSX Qiu","year":"2020","unstructured":"Qiu JSX, Hu J, Huang Z, Guo X, Liang X. Willingness to receive herpes zoster vaccine and factors influencing willingness among \u226550-year-old adults of Shanghai in May\u2013June 2020. Chin J Vaccines Immunization. 2020;27(307\u201310):27.","journal-title":"Chin J Vaccines Immunization"},{"key":"7840_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1080\/14760584.2021.1954910","volume":"20","author":"X Lu","year":"2021","unstructured":"Lu X, Lu J, Zhang L, Mei K, Guan B, Lu Y. Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50\u201369 years. Expert Rev Vaccines. 2021;20:1147\u201352.","journal-title":"Expert Rev Vaccines"},{"key":"7840_CR14","doi-asserted-by":"publisher","unstructured":"Gong L, Zhang X, Qu Z, Francis MR, Han K, Xu C, et al. Public interest in distribution and determinants of influenza and pneumonia vaccination during the COVID-19 pandemic: an infodemiology and cross-sectional study from China. Vaccines (Basel). 2021;9(11):1329. https:\/\/doi.org\/10.3390\/vaccines9111329.","DOI":"10.3390\/vaccines9111329"},{"key":"7840_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/vaccines9091016","volume":"9","author":"A Domnich","year":"2021","unstructured":"Domnich A, Grassi R, Fallani E, Spurio A, Bruzzone B, Panatto D, et al. Changes in attitudes and beliefs concerning vaccination and influenza vaccines between the first and second COVID-19 pandemic waves: a longitudinal study. Vaccines. 2021;9:1016.","journal-title":"Vaccines"},{"key":"7840_CR16","doi-asserted-by":"publisher","unstructured":"Domnich A, Cambiaggi M, Vasco A, Maraniello L, Ansaldi F, Baldo V, et al. Attitudes and beliefs on influenza vaccination during the COVID-19 pandemic: results from a representative Italian survey. Vaccines (Basel). 2020;8(4):711. https:\/\/doi.org\/10.3390\/vaccines8040711.","DOI":"10.3390\/vaccines8040711"},{"key":"7840_CR17","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1016\/j.vaccine.2021.04.062","volume":"26","author":"LAB Nicholls","year":"2021","unstructured":"Nicholls LAB, Gallant AJ, Cogan N, Rasmussen S, Young D, Williams L. Older adults\u2019 vaccine hesitancy: psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake. Vaccine. 2021;26:3520\u20137.","journal-title":"Vaccine"},{"key":"7840_CR18","doi-asserted-by":"publisher","unstructured":"Valente N, Lupi S, Stefanati A, Cova M, Sulcaj N, Piccinni L, et al. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study. BMJ Open. 2016;6(10):e011539. https:\/\/doi.org\/10.1136\/bmjopen-2016-011539.","DOI":"10.1136\/bmjopen-2016-011539"},{"key":"7840_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.vaccine.2019.01.010","volume":"9","author":"AK Shen","year":"2019","unstructured":"Shen AK, Warnock R, Selna W, MaCurdy TE, Chu S, Kelman JA. Vaccination among Medicare-fee-for service beneficiaries: characteristics and predictors of vaccine receipt, 2014\u20132017. Vaccine. 2019;9:1194\u2013201.","journal-title":"Vaccine"},{"key":"7840_CR20","doi-asserted-by":"publisher","unstructured":"Zein SA-O, Abdallah SB, Al-Smadi AA-O, Gammoh O, Al-Awaida WA-O, Al-Zein HJ. Factors associated with the unwillingness of Jordanians, Palestinians and Syrians to be vaccinated against COVID-19. PLoS Negl Trop Dis. 2021;15(12):e0009957. https:\/\/doi.org\/10.1371\/journal.pntd.0009957.","DOI":"10.1371\/journal.pntd.0009957"},{"key":"7840_CR21","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald NE, Hesitancy SWGOV. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33:4161\u20134.","journal-title":"Vaccine"},{"key":"7840_CR22","doi-asserted-by":"publisher","unstructured":"Bricout H, Torcel-Pagnon L, Lecomte C, Almas MF, Matthews I, Lu XA-O, et al. Determinants of shingles vaccine acceptance in the United Kingdom. PLoS One. 2019;14(8):e0220230. https:\/\/doi.org\/10.1371\/journal.pone.0220230.","DOI":"10.1371\/journal.pone.0220230"},{"key":"7840_CR23","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1080\/21645515.2021.1879579","volume":"17","author":"BJ Patterson","year":"2021","unstructured":"Patterson BJ, Chen CC, McGuiness CB, Glasser LI, Sun K, Buck PO. Early examination of real-world uptake and second-dose completion of recombinant zoster vaccine in the United States from October 2017 to September 2019. Hum Vaccin Immunother. 2021;17:2482\u20137.","journal-title":"Hum Vaccin Immunother"},{"key":"7840_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013706.pub2","volume":"7","author":"C Glenton","year":"2021","unstructured":"Glenton C, Carlsen B, Lewin S, Wennekes MD, Winje BA, Eilers R, et al. Healthcare workers\u2019 perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2021;7: CD013706. https:\/\/doi.org\/10.1002\/14651858.CD013706.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"7840_CR25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/21645515.2015.1008885","volume":"11","author":"TU Yang","year":"2015","unstructured":"Yang TU, Cheong HJ, Song JY, Noh JY, Kim WJ. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Hum Vaccin Immunother. 2015;11:719\u201326.","journal-title":"Hum Vaccin Immunother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07840-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07840-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07840-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:21:54Z","timestamp":1669512114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07840-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7840"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07840-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Chinese Academy of Medical Sciences and Peking Union Medical College (approval number: CAMS&PUMC-IEC-2021-034, approval date: October 12, 2021). Informed consent was obtained at the beginning of the survey, and those who failed to provide consent could not have access to the survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for the publication was obtained from participants for publication of this study. The corresponding authors had full access to all the data and the final responsibility of the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that might influence the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"888"}}